Methods

Patient Population
This was a single-center, non-randomized trial of 85 coronary artery disease (CAD) patients who were scheduled to undergo elective PCI for single, de novo lesions in native coronary arteries having a diameter between 2.5 and 4.0 mm. The patients with left main diseases, bifurcation lesions, graft stenosis, and left ventricular dysfunction were excluded. All patients gave their written, informed consent. All patients underwent angiographic and IVUS follow-up at 6 months. The patients returned for clinical visits at 1, 6 and 12 months, during which time the physicians were blinded to the angiographic and IVUS data.
Stent Implantation Procedure
Stent implantation was performed as previously described. 17 All implanted stents were bare metal MAC stent. All patients received aspirin (300 mg at least 12 h prior to stent implantation and 100-200 mg daily, indefinitely) and ticlopidine (500 mg at least 6 h prior to stent implantation and 250 mg daily continued for 30 days) or clopidogrel (300 mg at least 6 h prior to stent implantation and 75 mg daily continued for 30 days). A coronary angiogram was performed through the femoral or radial arteries. Dalteparin was administered 120 U/kg of body weight intravenously every 12 h or unfractionated heparin as an intravenous bolus (usually 5,000 units) followed by a continuous infusion at a dose adjusted according to the activated partial thromboplastin time. All stenotic lesions were pre-dilated and stents were deployed at 10-16 atm. Each angiogram or IVUS sequence was preceded by 200 to 300 g of intracoronary nitroglycerin.
Quantitative Coronary Angiography
Angiogram was analyzed with validated quantitative coronary angiography (QCA system; Phillips H5000 or Allular DCI program). Minimal luminal diameter, reference diameter and percentage diameter stenosis were measured in identical views before percutaneous balloon angioplasty and immediately after stent implantation.
Analysis of IVUS Images
We used the Endosonics IVUS system, which allows digital storage of pullback sequences. Automated pullbacks at 1 mm/s were performed before intervention and repeated after stenting. The IVUS measurements were performed at the tightest segment within the stent and the proximal and distal reference segments (defined as the location with the least amount of disease within 10 mm of the stent border without intervening branches). Quantitative 3-dimensional (D) reconstruction of the IVUS images was also performed. Trained catheterization laboratory personnel performed IVUS measurements, according to previously described methods. 18 Pre-interventional lesion and proximal and distal reference segment external elastic membrane (EEM), lumen, and plaque and media (P&M = EEM -lumen) crosssectional areas (CSA) and plaque burden (P&M/EEM) were measured. The lesion was the site with the smallest lumen CSA; if there were multiple image slices with the same minimum lumen CSA, then the slice with the largest EEM and P&M was measured. Pre-interventional arterial remodeling was assessed by comparing the lesion site EEM to the proximal and distal reference EEM CSA: positive remodeling (PR, lesion > proximal reference), intermediate remodeling (IR, distal reference < lesion < proximal reference), and negative remodeling (NR, lesion < distal reference). Remodeling index (RI) was defined as follows: the target lesion EEM CSA divided by the average of the proximal and distal reference EEM CSA. Post-interventional and follow-up stent, lumen, and NIH (stent minus lumen CSA) areas were measured. Post-interventional stent eccentricity was calculated as minimum divided by maximum stent diameter. Vessel, stent, and luminal volumes were measured and in-stent neointimal proliferation volume was obtained as stent-luminal volume.
The patients were observed for major adverse cardiac events (MACE) such as death, cerebrovascular accident, acute myocardial infarction, repeat PCI, and bypass graft during hospitalization. The angiographic restenosis was observed at 6 months after PCI and the MACE was observed at 1-year clinical follow-up. Angiographic restenosis was defined as stenosis more than 50% of the target lesion on follow-up coronary angiogram.
Statistical Analysis
Statistical analysis was performed with the aid of the commercially available software (SPSS Version 11). For the statistical analyses, the unpaired t-test, chi-squared test were performed and the results were designated as the mean value ± SD or number (%) of patients. A value of p<0.05 was considered as significant.
Results
Patient and Lesion Characteristics
The patient and lesion characteristics are listed in Table 1 . There were no differences in demographic data and QCA findings and laboratory data between the 2 groups. Stable angina was observed more frequently in the NR group and acute coronary syndrome (ACS) was observed more frequently in the PR/IR group.
Angiographic Results
Angiographic results are summarized in Table 2 . On diagnostic coronary angiogram, the multivessel diseases were observed more frequently in the PR/IR group and there was no significant difference in the incidence of intraluminal thrombi. On the follow-up angiogram, the late loss was significantly larger in the PR/IR group (0.82±0.34 mm vs 0.32±0.42 mm; p=0.003).
IVUS Analysis
The IVUS results are shown in Table 3 . The RI was 1.09±0.20 in the PR/IR group and 0.84±0.12 in the NR group (p=0.001). There was no difference in the lumen CSA in both group prior to stenting (3.3±0.7 mm 2 vs 3.2±1.0 mm 2 ; p=0.897) and after stenting (7.2±1.4 mm 2 vs 7.3±1.3 mm 2 ; p=0.898). Pre-intervention lesion P&M CSA was significantly larger in the PR/IR group (9.2±2.9 mm 2 vs 6.2±1.8 mm 2 ; p=0.001) and the plaque burden was significantly higher in the PR/IR group (73.6±8.3% vs 65.8± 7.8%; p=0.032). A significant positive correlation was found between pre-interventional RI and pre-interventional P&M CSA and plaque burden (r=0.57, r=0.42; p<0.001, p<0.001) (Fig 1) . At post-intervention, there were no significant differences in stent eccentricity and the incidence of tissue prolapse between both groups. At 6 month followup, intra-stent lumen area was significantly smaller in the PR/IR group (3.8±0.8 mm 2 vs 5.7±1.6 mm 2 ; p=0.001) and NIH area was significantly larger in the PR/IR group 3 in the NR group (p=0.001), and the percentage change of neoimtima hyperplasia volume was 43±18% in the PR/IR group and 26±16% in the NR group (p=0.001). The lumen volume was significantly smaller in the PR/IR group than that in the NR group, and neointima hyperplasia volume were significantly larger in the PR/IR group than that in the NR group. A significant positive correlation was found between pre-interventional RI and follow-up NIH CSA (r=0.25, p=0.022) and a significant negative correlation was found between pre-interventional RI and follow-up lumen CSA (r=0.25, p=0.024) (Fig 2) .
MACE During Hospitalization and 1-Year Clinical
Follow-up Data regarding clinical outcomes are shown in Table 4 . A 1-year clinical follow-up was performed in all patients. Follow-up angiogram was performed in all patients. No inhospital MACE occurred in the patients. At the 6-month follow-up angiogram, the incidence of ISR was significantly higher in the PR/IR group (30.8% vs 18.2%; p=0.032). The diffuse ISR was observed more frequently in the PR/IR group (62.5% vs 33.3%; p=0.001), and focal ISR was observed more frequently in the NR group (37.5% vs 66.7%; p=0.001). The incidence of repeat PCI was significantly higher in the PR/IR group (28.8% vs 15.2%; p=0.035). No reinfarction, bypass graft, stroke or death occurred at the 1-year clinical follow-up.
Discussion
The main findings in the present study revealed that preinterventional P&M CSA and the degree of NIH after stenting were significantly larger in the PR/IR group than in the NR group. Pre-interventional RI correlated with the extent of pre-interventional P&M CSA, pre-interventional plaque burden and follow-up in-stent NIH.
Several studies using IVUS before the intervention have described various characteristics of coronary remodeling and plaque morphology in the culprit lesion of CAD. 9, 19, 20 Nakamura et al reported that PR was observed more frequently in ACS than in stable angina and the RI was greater in ACS than in stable angina. 21 In addition, Imazeki et al reported that PR was present in 61.3% in the patients with ACS, but in none of the patients with stable angina by multislice computed tomography and IVUS study. 22 In the present study, the prevalence of ACS was significantly higher in the PR/IR group than in the NR group. This finding may reflect the impact of remodeling types and its degree in the culprit lesion of CAD on clinical presentation. A certain characteristic of coronary remodeling may be observed in the culprit lesion of ACS with IVUS, and, if so, it may be possible to predict the plaque instability leading to ACS.
The mechanisms of restenosis in stented lesions differ from those in non-stented lesions. 4, 6, 7, 23 After balloon angioplasty, late constriction of the EEM CSA appeared to play a more significant role in causing restenosis than did NIH. However, after stenting was performed, the stents prevented the remodeling process of late vessel-constriction, and restenosis was the result of uniform neointimal tissue proliferation throughout the stent. 24, 25 Nishioka et al first proposed the classification of remodeling used in the present study. 9 Using this classification, Endo et al showed that pre-interventional remodeling influenced NIH in 113 selected patients treated with a single stent. 15 In Endo's study, % NIH measured 51±19% in PR, 42±18% in IR, and 35±20% in NR lesions. Mintz et al reported about the impact of pre-interventional arterial remodeling on NIH after implantation of non-polymerencapsulated paclitaxel-coated stents. 26 In Mintz's study, % NIH measured 18±13% in PR, 23±22% in IR, and 6±20% in NR lesions. Therefore, they concluded that drug-eluting stents may have a greater effect on reducing NIH accumulation in lesions with pre-interventional NR characteristics. In the present study, intra-stent NIH area was larger in the PR/IR group than in the NR group. Strong positive correlation was found between pre-interventional RI and pre-interventional P&M CSA, plaque burden and follow-up NIH CSA. An accelerated intimal growth through the metallic stent struts in response to overall vessel irritation may be responsible for the unfavorable clinical outcomes observed in the PR vessels. Because PR has been detected more frequently in unstable lesions, 27, 28 lesions with PR may be more biologically active. The vessel area has been shown to increase to compensate for plaque growth outside the stent following stenting. 24 Lack of this adaptive remodeling process in lesions with PR may also be responsible for an increasing ISR. 29 There are several limitations to be mentioned for the present study. First, the group sizes are relatively small. Second, because pre-interventional IVUS imaging was performed based on each operator's decision, lesion selection may be biased. Third, for the determination of vascular remodeling, only a single IVUS image in the culprit lesion was assessed. The lesion may feature various geometric differences along its length, so that the chosen frame may not be characteristic of certain biological properties of the entire stenosis.
Conclusion
In conclusion, the results of the present study suggest that pre-intervention IVUS imaging may be important prior to stenting. Pre-interventional arterial remodeling influenced the development of NIH after stenting and that preinterventional RI correlated with the extent of pre-interventional plaque area and follow-up in-stent NIH.
